Propel Health Medical Affairs (PHMA), a Gladstone-based medical communications agency within the Propel Health network, recently announced the appointment of Daniel Snyder, PhD, as its new executive vice president, Advisory Services.
In this key leadership role, Snyder will directly support pharmaceutical and biotechnology clients in developing and executing Medical Affairs launch plans. His primary focus will be ensuring that clients are fully prepared for every stage of introducing a new product to the market.
Snyder brings more than two decades of client-facing launch leadership experience and is renowned for his hands-on approach to achieving launch excellence amid complex market realities. His expertise spans all core areas of pre-launch readiness, including:
-
Integrated evidence planning
-
Scientific strategy development
-
Expertise across 11 therapeutic areas
-
Market preparation
He has a proven track record of successfully leading and supporting the launch of multiple breakthrough products. Snyder possesses deep, practical knowledge in critical areas such as aligning cross-functional teams, building strong Key Opinion Leader (KOL) partnerships, and supporting payer and provider engagement to ensure scientific communication is impactful and compliant.
Clients working with Snyder will benefit from his counsel in shaping launch plans, optimizing Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) strategy, and delivering operational excellence for every pre-launch milestone.
Jeff Keller, president of Propel Health Medical Affairs, expressed his enthusiasm for the new hire. “I am delighted to have Daniel join us not just for his expertise, but for his wisdom, honesty, and unwavering dedication to helping our partners succeed,” Keller said. “Daniel’s integrity and commitment shine through in every project, and our clients will immediately feel the difference in working with him.”
DSnyder is known for his ability to translate complex evidence and strategy into executable solutions that maximize resources and drive measurable results for both companies and patients. He has previously built Medical Affairs, HEOR, and RWE organizations from the ground up, driving Medical Excellence in prior roles.
